UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epithelial ovarian carcinoma in the reproductive age group

Cancer, 1999-06, Vol.85 (12), p.2623-2629

1999

Volltextzugriff (PDF)

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Cancer, 2000-10, Vol.89 (7), p.1532-1540

2000

Volltextzugriff (PDF)

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

Cancer research (Chicago, Ill.), 2004, Vol.64 (1), p.202-208

2004

Volltextzugriff (PDF)

A Phase I Study of Continuous Infusion Doxorubicin and Paclitaxel Chemotherapy with Granulocyte Colony-Stimulating Factor for Relapsed Epithelial Ovarian Cancer

Clinical cancer research, 1999-06, Vol.5 (6), p.1299-1305

1999

Volltextzugriff (PDF)

Clinically significant venous thromboembolism after gynecologic surgery

Journal of reproductive medicine, 1999-08, Vol.44 (8), p.669

1999

Volltextzugriff (PDF)

Hypersensitivity reactions to cetuximab

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13054-e13054

2011

Volltextzugriff (PDF)

A gene expression algorithm for the prediction of platinum sensitivity in ovarian cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5021-5021

2010

Volltextzugriff (PDF)

Advanced stage serous papillary ovarian cancer: Impact of histological grade in clinical outcomes

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16579-16579

2008

Volltextzugriff (PDF)

Phase II multi-institutional study of docetaxel plus aflibercept (AVE0005, NSC# 724770) in patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5017-5017

2011

Volltextzugriff (PDF)

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5066-5066

2011

Volltextzugriff (PDF)

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5047-5047

2011

Volltextzugriff (PDF)

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5528-5528

2008

Volltextzugriff (PDF)

Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5523-5523

2008

Volltextzugriff (PDF)

Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo

Cancer biology & therapy, 2005-01, Vol.4 (1), p.110-114

2005

Volltextzugriff (PDF)

Advances in the surgical management of ovarian cancer

Journal of reproductive medicine, 2005-06, Vol.50 (6), p.454

2005

Volltextzugriff (PDF)

Cervical adenocarcinoma survival among Hispanic and white women: A multicenter cohort study

American journal of obstetrics and gynecology, 2003-03, Vol.188 (3), p.640-644

2003

Volltextzugriff (PDF)

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Cancer, 2020-11, Vol.126 (22), p.4948-4956

2020

Volltextzugriff (PDF)

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

The New England journal of medicine, 2023-12, Vol.389 (23), p.2162-2174

2023

Volltextzugriff (PDF)

A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response

Clinical cancer research, 2021-05, Vol.27 (10), p.2734-2741

2021

Volltextzugriff (PDF)

Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas

Clinical cancer research, 2019-04, Vol.25 (8), p.2450-2457

2019

Volltextzugriff (PDF)

Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients

Critical care (London, England), 2023-11, Vol.27 (1), p.428-428, Article 428

2023

Volltextzugriff (PDF)

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

The New England journal of medicine, 2005-02, Vol.352 (6), p.558-569

2005

Volltextzugriff (PDF)

UPGRADE-A: Phase 1 expansion trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi) in combination with carboplatin in patients with high-grade serous ovarian cancer (HGSOC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS5613-TPS5613

2023

Volltextzugriff (PDF)

EZH2/EZH1 inhibitor tulmimetostat (CPI-0209) in patients with advanced solid tumors or hematologic malignancies: Preliminary phase II results

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3094-3094

2023

Volltextzugriff (PDF)

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5514-5514

2022

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epithelial ovarian carcinoma in the reproductive age group

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer

A Phase I Study of Continuous Infusion Doxorubicin and Paclitaxel Chemotherapy with Granulocyte Colony-Stimulating Factor for Relapsed Epithelial Ovarian Cancer

Clinically significant venous thromboembolism after gynecologic surgery

Hypersensitivity reactions to cetuximab

A gene expression algorithm for the prediction of platinum sensitivity in ovarian cancer

Advanced stage serous papillary ovarian cancer: Impact of histological grade in clinical outcomes

Phase II multi-institutional study of docetaxel plus aflibercept (AVE0005, NSC# 724770) in patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: Gynecologic Oncology Group study 9921

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD)

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo

Advances in the surgical management of ovarian cancer

Cervical adenocarcinoma survival among Hispanic and white women: A multicenter cohort study

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response

Clinical and Genomic Implications of Luminal and Basal Subtypes Across Carcinomas

Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection

UPGRADE-A: Phase 1 expansion trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi) in combination with carboplatin in patients with high-grade serous ovarian cancer (HGSOC)

EZH2/EZH1 inhibitor tulmimetostat (CPI-0209) in patients with advanced solid tumors or hematologic malignancies: Preliminary phase II results

A randomized phase II study of bevacizumab and weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant or refractory ovarian cancer NCI trial#10150

Aktive Filter

Suchergebnisse filtern